OCA-话题@MedSci

#OCA#

52篇内容 | 2016人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1927913, encodeId=9431192e913a4, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=Nature: 抑制肥胖新靶点：骨分泌lipocalcin2蛋白通过黑皮质素（melanocortin）4受体抑制食欲, objectType=article, longId=91323, objectId=a3389132327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3389132327, replyNumber=0, likeNumber=93, createdTime=2017-08-09, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3389132327, moduleTitle=Nature: 抑制肥胖新靶点：骨分泌lipocalcin2蛋白通过黑皮质素（melanocortin）4受体抑制食欲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3389132327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927916, encodeId=4bc0192e916ae, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=Hippocampus: 唤醒老年痴呆症小鼠“失去的”记忆, objectType=article, longId=107851, objectId=676310e851e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=676310e851e1, replyNumber=0, likeNumber=62, createdTime=2018-05-17, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=676310e851e1, moduleTitle=Hippocampus: 唤醒老年痴呆症小鼠“失去的”记忆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=676310e851e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927912, encodeId=2b79192e9122c, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=Circulation：Circulation：他汀、ACEI/ARB与β受体阻滞剂在MINOCA性心肌梗死中的疗效比较, objectType=article, longId=88607, objectId=ad908860e05, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad908860e05, replyNumber=0, likeNumber=60, createdTime=2017-11-07, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad908860e05, moduleTitle=Circulation：Circulation：他汀、ACEI/ARB与β受体阻滞剂在MINOCA性心肌梗死中的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad908860e05)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927917, encodeId=e2e2192e9174f, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=HIPPOCAMPUS :唤醒老年痴呆症小鼠“失去的”记忆, objectType=article, longId=107884, objectId=dabf10e8847f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dabf10e8847f, replyNumber=0, likeNumber=76, createdTime=2018-01-05, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dabf10e8847f, moduleTitle=HIPPOCAMPUS :唤醒老年痴呆症小鼠“失去的”记忆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dabf10e8847f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927914, encodeId=6331192e91413, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=CCLM：ImmunoCAP®ISAC 112的性能评估, objectType=article, longId=98809, objectId=be3298809fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be3298809fb, replyNumber=0, likeNumber=71, createdTime=2017-09-29, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be3298809fb, moduleTitle=CCLM：ImmunoCAP®ISAC 112的性能评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be3298809fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927911, encodeId=2f83192e91148, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=Nature：一种独特的蛋白设计可诱导包含蛋白纳米笼（nanocages）的细胞外膜泡的形成, objectType=article, longId=84260, objectId=15428426077, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15428426077, replyNumber=0, likeNumber=98, createdTime=2017-08-09, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15428426077, moduleTitle=Nature：一种独特的蛋白设计可诱导包含蛋白纳米笼（nanocages）的细胞外膜泡的形成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15428426077)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927910, encodeId=54c0192e91037, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=Intercept原发性胆汁胆管炎新药Ocaliva获CHMP支持批准, objectType=article, longId=80911, objectId=9648809117f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9648809117f, replyNumber=0, likeNumber=71, createdTime=2017-02-24, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9648809117f, moduleTitle=Intercept原发性胆汁胆管炎新药Ocaliva获CHMP支持批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9648809117f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927909, encodeId=9e14192e909f5, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=LEUKOCARE授予美国疫苗公司PaxVax许可, objectType=article, longId=77383, objectId=e96be73835c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e96be73835c, replyNumber=0, likeNumber=55, createdTime=2017-02-15, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e96be73835c, moduleTitle=LEUKOCARE授予美国疫苗公司PaxVax许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e96be73835c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927908, encodeId=0e42192e9084d, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=J Am Soc Echocardiogr：主动脉狭窄低血流量相关因素, objectType=article, longId=60268, objectId=6e21602680e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e21602680e, replyNumber=0, likeNumber=97, createdTime=2016-01-13, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e21602680e, moduleTitle=J Am Soc Echocardiogr：主动脉狭窄低血流量相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e21602680e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927906, encodeId=8564192e90692, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=FDA授予原发性胆汁性肝硬化治疗药物OCA优先审查资格, objectType=article, longId=55620, objectId=0b5e55620ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b5e55620ec, replyNumber=0, likeNumber=64, createdTime=2016-05-22, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b5e55620ec, moduleTitle=FDA授予原发性胆汁性肝硬化治疗药物OCA优先审查资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b5e55620ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927907, encodeId=2153192e90796, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=Hippocampus：甜食可增强记忆, objectType=article, longId=59019, objectId=19fa590197c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19fa590197c, replyNumber=0, likeNumber=85, createdTime=2016-04-12, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19fa590197c, moduleTitle=Hippocampus：甜食可增强记忆, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19fa590197c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1927905, encodeId=a037192e9058c, content=<a href='/topic/show?id=f7fb13216dc' target=_blank style='color:#2F92EE;'>#OCA#</a>, objectTitle=Gastroenterology：OCA（法尼酯衍生物X受体拮抗剂）用于治疗2型糖尿病及非酒精性脂肪肝患者的有效性及安全性, objectType=article, longId=23911, objectId=850f23911e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=850f23911e1, replyNumber=0, likeNumber=68, createdTime=2013-11-18, rootId=0, userName=smlt2008, userId=c39f145, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=850f23911e1, moduleTitle=Gastroenterology：OCA（法尼酯衍生物X受体拮抗剂）用于治疗2型糖尿病及非酒精性脂肪肝患者的有效性及安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=850f23911e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

OCA

2020-05-29

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

Nature: 抑制肥胖新靶点：骨分泌lipocalcin2蛋白通过黑皮质素（melanocortin）4受体抑制食欲

2017-08-09

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

Hippocampus: 唤醒老年痴呆症小鼠“失去的”记忆

2018-05-17

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

Circulation：Circulation：他汀、ACEI/ARB与β受体阻滞剂在MINOCA性心肌梗死中的疗效比较

2017-11-07

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

HIPPOCAMPUS :唤醒老年痴呆症小鼠“失去的”记忆

2018-01-05

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

CCLM：ImmunoCAP®ISAC 112的性能评估

2017-09-29

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

Nature：一种独特的蛋白设计可诱导包含蛋白纳米笼（nanocages）的细胞外膜泡的形成

2017-08-09

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

Intercept原发性胆汁胆管炎新药Ocaliva获CHMP支持批准

2017-02-24

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

LEUKOCARE授予美国疫苗公司PaxVax许可

2017-02-15

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

J Am Soc Echocardiogr：主动脉狭窄低血流量相关因素

2016-01-13

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

FDA授予原发性胆汁性肝硬化治疗药物OCA优先审查资格

2016-05-22

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

Hippocampus：甜食可增强记忆

2016-04-12

smlt2008 (审核中...)

前往app查看评论内容

#OCA#

Gastroenterology：OCA（法尼酯衍生物X受体拮抗剂）用于治疗2型糖尿病及非酒精性脂肪肝患者的有效性及安全性

2013-11-18

科室
- - 订阅+
  - 更多科室
工具
服务